Official Ninja Nerd Website: https://ninjanerd.org
Ninja Nerds!
In this lecture Professor Zach Murphy will be presenting on Molnupiravir. This drug has been developed by Merck and is indicated for patients with mild to moderate COVID-19 to be taken orally. During this lecture we will be discussing the mechanism of action (MOA) and pharmacology for Molnupiravir, intended population, efficacy and safety concerns. We hope you enjoy this lecture and be sure to support us below!
COVID-19 Pill | Molnupiravir References:
https://docs.google.com/document/d/1xIDorHk6xTpxSYjrEeqZJ65FTkoByT7PiDSWxe2pix4/edit?usp=sharing
Table of Contents:
0:00 Lab
0:08 Molnupiravir Introduction
1:49 Mechanism of Action (MOA)
7:31 Molnupiravir Pharmacology
12:02 Population Targeted
13:48 Efficacy
17:45 Safety Concerns
32:40 Comment, Like, SUBSCRIBE!
Join this channel to get access to perks:
https://www.youtube.com/channel/UC6QYFutt9cluQ3uSM963_KQ/join
APPAREL |
https://www.amazon.com/s?k=ninja+nerd&ref=nb_sb_noss_2
DONATE
PATREON | https://www.patreon.com/NinjaNerdScience
PAYPAL | https://www.paypal.com/paypalme/ninjanerdscience
SOCIAL MEDIA
FACEBOOK | https://www.facebook.com/NinjaNerdlectures
INSTAGRAM | https://www.instagram.com/ninjanerdlectures
TWITTER | https://twitter.com/ninjanerdsci
@NinjaNerdSci
DISCORD | https://discord.gg/3srTG4dngW
#ninjanerd #Molnupiravir #COVID19